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Background: Dma1 inhibits cytokinesis during a mitotic checkpoint by ubiquitinating Sid4, a major scaffold for the Polo-
like kinase Plo1.
Results: Dma1 RING domain dimerization is required for proper localization, E3 activity, and checkpoint function.
Conclusion: Dma1 dimerization is required to efficiently ubiquitinate its substrates.
Significance: Dma1 is related to the human checkpoint proteins CHFR and RNF8, which might have similar structural
properties as Dma1.
In fission yeast (Schizosaccharomyces pombe), the E3 ubiqui-
tin ligaseDma1delays cytokinesis if chromosomes are not prop-
erly attached to themitotic spindle.Dma1 contains aC-terminal
RING domain, and we have found that the Dma1 RING domain
forms a stable homodimer. Although the RING domain is
required for dimerization, residues in the C-terminal tail are
also required to help form or stabilize the dimeric structure
because mutation of specific residues in this region disrupts
Dma1 dimerization. Further analyses showed that Dma1
dimerization is required for proper localization at spindle pole
bodies and the cell division site, E3 ligase activity, and mitotic
checkpoint function.Thus,Dma1 forms anobligate dimer via its
RING domain, which is essential for efficient transfer of ubiqui-
tin to its substrate(s). This study further supports themechanis-
tic paradigm that many RING E3 ligases function as RING
dimers.
E3 ubiquitin ligases facilitate the final step in protein ubiq-
uitination by promoting transfer of ubiquitin (Ub)2 from the E2
enzyme to a target lysine residue on the substrate (1). Two
distinct classes of E3 ligases exist, which are classified by the
presence of either a RING or HECT domain. RING domain E3
ligases have been thought to act mainly as scaffolds to bring the
E2Ub complex in proximity to the substrate (2); however,
recent evidence suggests that RING domains might also allos-
terically activate their cognate E2 (3). In contrast, HECT
domain E3 ligases first ligate ubiquitin to an active cysteine
residue on themselves before actively catalyzing ubiquitination
of the substrate (4). In addition to either a HECT or RING
domain, many E3 ligases also contain a substrate recognition
motif that provides substrate specificity.
The Schizosaccharomyces pombe checkpoint protein Dma1
is a RINGE3 ligase that inhibits cytokinesis if chromosomes are
not segregated properly (5, 6). Dma1 contains a C-terminal
RING domain and an N-terminal phospho-binding FHA
domain, which is required for its localization to spindle pole
bodies (SPBs) and the cell division site and likely confers sub-
strate specificity to Dma1 (5). During a mitotic checkpoint
arrest, Dma1 ubiquitinates Sid4, a major scaffold for the Polo-
like kinase Plo1, and thereby impedes Plo1 localization to SPBs
(7). Because SPB-localized Plo1 is required for activation of the
septation initiation network (SIN), which triggers cytokinesis,
ubiquitination of Sid4 restricts the ability of Plo1 to promote
cytokinesis (7).
Many RING domain E3 ligases canmultimerize, and this has
proven to be important for their function; however, the nature
of these oligomer complexes varies widely. Some RING E3
ligases, such as RNF4 (8), cIAP (9), and Siah (10), self-interact to
form homodimers, whereas others interact with distinct RING
E3 ligases to form heterodimers, such as Mdm2-MdmX (11),
Ring1b-Bmi1 (12), and BRCA1-BARD1 (13). In addition to
these smaller complexes, some RING E3 ligases can also form
higher order oligomers either with themselves or with other
RING E3 ligases (14). Although it is not completely clear why
many RING E3 ligases need to multimerize for their function,
recent studies suggests that two RING domains might be
required to spatially accommodate the E2Ub conjugate (15).
In this study, we found that Dma1 forms a homodimer via its
RING domain and that dimerization is required for its E3 ligase
activity. Accordingly, mutant cells expressing a constitutively
monomeric form of Dma1 are defective in their mitotic check-
point response, and Sid4 ubiquitination is abolished, demon-
strating that Dma1 requires dimerization in vivo. Furthermore,
in the absence of dimerization, Dma1 has reduced localization
at SPBs and the cell division site, suggesting that dimerization is
required for proper Dma1 localization. Because Dma1 is func-
tionally related to human checkpoint proteins CHFR and RNF8
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(16), it is likely that these proteins have similar structural
properties.
EXPERIMENTAL PROCEDURES
General Yeast Methods—S. pombe strains (Table 1) were
grown in yeast extract medium supplemented with the appro-
priate amino acids (17). For diploid construction, strains of
opposite mating type and complementary adenine markers
(ade6-M210 and ade6-M216) were crossed at 25 °C on sporu-
lation medium and then plated onto minimal medium lacking
adenine 24 h later to select for diploids at 32 °C. For dma1
mutant constructions, a pIRT2 plasmid containing the dma1
open reading frame plus 500 bp of 5- and 3-flanking
sequences was mutated using a site-directed mutagenesis kit
(Agilent Technologies). Gene replacements at the endogenous
dma1 locus were carried out as described previously (7), and
stable integrants were selected based on resistance to 5-fluo-
roorotic acid. We validated all mutants by colony PCR using
primers outside of the dma1 5- and 3-flanking sequences.
Protein Methods—S. pombe cell pellets were lysed by bead
disruption as described previously (18), with the exception that
a complete protease inhibitormixture (Calbiochem) was added
to the Nonidet P-40 buffer prior to lysis. For immunoprecipita-
tion experiments, 2 g of anti-GFP (Roche Applied Science),
anti-FLAG (Sigma), or anti-V5 (Invitrogen) antibody was used
with protein G-Sepharose (GE Healthcare). Immunoblotting
was performed with anti-GFP, anti-FLAG, or anti-V5 antibody
and a fluorescent mouse secondary antibody (LI-COR Biosci-
ences) at the manufacturers’ recommended concentration.
For in vitro ubiquitination assays, Dma1-GFP immunopre-
cipitates werewashed three timeswithNonidet P-40 buffer and
twice with reaction buffer (50 mM Tris, 2.5 mM MgCl2, and 0.5
mM DTT, pH 7.5). Washed beads were then incubated with
recombinant E1 (Boston Biochem), the Ubc13-Uev1 E2 com-
plex (Boston Biochem), 15 M ubiquitin (Sigma), and 2 mM
ATP in reaction buffer. Reactions were incubated on a Vor-
Temp shaker for 90 min at 25 °C. Proteins were run on a 3–8%
Tris acetate gel (Invitrogen) and immunoblottedwith anti-GFP
antibody.
Analytical Ultracentrifugation—Recombinant His6-Dma1-
(187–end) fusion proteinwas produced in BL21 cells by isopro-
pyl -D-thiogalactopyranoside induction overnight at 18 °C.
Bacterial cells were lysed by sonication, and proteinswere affin-
ity-purified onHisBind resin (Novagen) inHisBindbuffer (500
mM NaCl, 40 mM Tris-HCl, and 5 mM imidazole, pH 7.9). The
resin was washed with 20 volumes of HisBind buffer, and pro-
tein was eluted with elution buffer (500 mM NaCl, 20 mM Tris-
HCl, and 1 M imidazole, pH 7.9). His6-Dma1(187–end) was
then purified by gel filtration using an S-200 column (GE
Healthcare) in buffer containing 10 mM Tris-HCl, pH 7.4, and
either 150 mM NaCl or 500 mM NaCl. Peak elution fractions
were visualized on a Coomassie Blue-stained gel (Sigma). Frac-
tions were combined and concentrated using a Microcon
column (3,000 molecular weight cutoff, Millipore). His6-
Dma1(187–end) recombinant protein (1 mg/ml) was run on
an Optima XLI ultracentrifuge (Beckman Coulter) equipped
with a four-hole An-60 Ti rotor at 42,000 rpm at 4 °C. Samples
were loaded into double-sector cells (path length of 1.2 cm)
with charcoal-filled Epon centerpieces and quartz windows.
Sedfit (version 12.0) (19) was used to analyze velocity scans
using every eight scans from a total of 393 scans. Approximate
size distributions were determined for a confidence level of p
0.95, a resolution of n  300, and sedimentation coefficients
between 0 and 10 S.
Yeast Two-hybrid Methods—Dma1 fragments were cloned
into bait and prey plasmids pGBT9 and pGAD424, respectively
(20). Point mutations were made in pGBT9-dma1(187–end)
and pGAD424-dma1(187–end) plasmids using the site-di-
rected mutagenesis kit and were sequence-verified. Bait and
prey plasmids were simultaneously transformed into strain
KGY1296 (Table 1) using a standard LiAc transformation
procedure, and transformants were selected for growth on
synthetic medium supplemented with methionine, uracil, his-
tidine, and adenine but lacking leucine and tryptophan. Two-
hybrid interactions were tested on synthetic medium supple-
mented with methionine and uracil but lacking leucine,
tryptophan, histidine, and adenine.
TABLE 1
Yeast strains used in this study
RFP, red fluorescent protein.
Strain Genotype Ref.
KGY7811 h dma1-V5::kanR ade6-M210 ura4-D18 leu1-32 This study
KGY12765 h dma1-3-FLAG::kanR ade6-M216 ura4-D18 leu1-32 This study
KGY13101 h/h dma1-V5::hygR/dma1-3-FLAG::kanR ade6-M210/ade6-M216 leu1-32/leu1-32 ura4-D18/ura4-D18 This study
KGY12781 h dma1(L241A,V245A)-V5::kanR ade6-M210 ura4-D18 leu1-32 This study
KGY12709 h dma1(L241A,V245A)-3-FLAG::kanR ade6-M216 ura4-D18 leu1-32 This study
KGY13526 h/h dma1(L241A,V245A)-V5::kanR/dma1(L241A,V245A)-3-FLAG::kanR ade6-M210/ade6-M216
leu1-32/leu1-32 ura4-D18/ura4-D18
This study
KGY11605 h dma1-GFP::kanR sid4-RFP::kanR ade6-M21X ura4-D18 leu1-32 7
KGY13085 h dma1(L241A,V245A)-GFP::kanR sid4-RFP::hygR ade6-M216 leu1-32 ura4-D18 This study
KGY13370 h dma1(F206A)-GFP::kanR sid4-RFP::hygR ade6-M216 leu1-32 ura4-D18 This study
KGY13112 h dma1(L241A,V245A)-GFP::kanR cdc7-3-mChery::kanR ade6-M21X leu1-32 ura4-D18 This study
KGY13110 h sid4-SA1 dma1(L241A,V245A)-GFP::kanR sad1-RFP::hygR ade6-M21X leu1-32 ura4-D18 This study
KGY13366 h dma1(R64A,L241A,V245A)-GFP::kanR ade6-M216 ura4-D18 leu1-32 This study
KGY13124 h nda3-KM311 dma1(L241A,V245A)-GFP::kanR ade6-M21X ura4-D18 leu1-32 This study
KGY13387 h nda3-KM311 dma1::kanR ade6-M21X leu1-32 ura4-D18 This study
KGY5637 h nda3-KM311 ade6-M210 leu1-32 ura4-D18 lab stock
KGY1296 PJ69–4A MAT trp1-901 leu2-3,112 ura3-52 his3-200 gal4 gal80 LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ 20
KGY13966 h nda3-KM311 dma1(F206A)-GFP::kanR ade6-M21X ura4-D18 leu1-32 This study
KGY14036 h/h dma1(F206A)-V5::hygR/dma1(F206A)-3-FLAG::kanR ade6-M210/ade6-M216 leu1-32/leu1-32 ura4-D18/ura4-D18 This study
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Microscopy Methods—All fixed and live cell fluorescence
microscopy was performed on a spinning disk confocal micro-
scope (UltraView LCI, PerkinElmer Life Sciences) as described
previously (7). For DAPI and methyl blue staining, cells were
fixed in 70% ethanol for 30 min and washed with PBS prior to
staining.
RESULTS
Dma1 Self-associates in Vivo via Its RINGDomain—Because
many RING E3 ubiquitin ligases self-associate to form
homodimers or associate with other RING E3 ligases to form
heterodimers, we asked whether Dma1 self-associates in vivo.
Diploid cells were generated in which one allele of dma1 was
tagged with sequences encoding a V5 epitope and the other
dma1 allele was tagged with sequences encoding a FLAG3
epitope. By immunoprecipitation, we found that Dma1-FLAG3
and Dma1-V53 could interact in vivo (Fig. 1A). Furthermore,
full-lengthDma1 could interact with itself in a yeast two-hybrid
experiment (Fig. 1, B and C), suggesting that this interaction
might be direct.
We then tested a variety of Dma1 fragments in a yeast two-
hybrid assay to map the region of self-interaction. Deletion of
the N-terminal FHA domain and mid-region (amino acids (aa)
1–186) did not affect Dma1 self-interaction; however, deletion
of the RING domain and the C-terminal residues flanking the
RING domain (aa 192–end) abolished the interaction (Fig. 1, B
and C), indicating that this region is necessary for self-interac-
tion. The RING domain with the C-terminal tail (aa 187–end)
interactedwith both full-lengthDma1 and itself, and truncating
the C-terminal tail on this fragment to aa 246 did not abolish
the interaction (Fig. 1, B andC). However, truncating the entire
C-terminal tail abolished the interaction, and the C-terminal
tail alone (aa 240–252) was not sufficient for interaction (Fig. 1,
B and C), indicating that the RING domain and at least 10 res-
idues flanking the RING domain are required for the interac-
tion. Thus, the Dma1 self-interaction region is contained in aa
187–246, which includes the RING domain.
Dma1 RING Domain Forms a Dimer—We next determined
the oligomeric state of the Dma1 RING domain. Recombinant
His6-Dma1(187–end) was affinity-purified on HisBind resin
followed by gel filtration, and its approximate molecular mass
was determined by sedimentation velocity analytical ultracen-
trifugation (SVAU) (Fig. 2A). SVAU traces of His6-Dma1(187–
end) in 150 mM NaCl indicated that the majority (66%) of the
protein exists in an23-kDa complex (s 1.5), consistent with
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FIGURE 1. Dma1 self-associates in vivo. A, co-immunoprecipitation of
Dma1-3-V5 and Dma1-3-FLAG from diploid cells. IP, immunoprecipitation;
WB, Western blot. B, yeast two-hybrid interactions using full-length (F/L)
Dma1 and Dma1 fragments as bait and prey. C, schematics of Dma1 frag-
ments that were tested for yeast two-hybrid interaction and summary of their
interactions. , interaction comparable with the wild type; , no interac-
tion detected; NT, not tested.
FIGURE 2. Dma1 RING domain preferentially forms a dimer in vitro.
A, His6-Dma1(187– end) was affinity-purified on HisBind resin followed by gel
filtration. Fractions 15–20 were combined and concentrated for SVAU.
B, expected sizes of Dma1 oligomers. C, SVAU analysis of His6-Dma1(187–
end) in 150 mM NaCl. s values, determined molecular masses, and percent
abundance are given for each indicated peak. RMSD, root mean square devi-
ation. D, SVAU analysis of His6-Dma1(187– end) in 500 mM NaCl. s values,
determined molecular masses, and percent abundance are given for each
indicated peak.
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and 109-kDa species were also detected; however, these spe-
cies made up only 22 and 11% of the total population, respec-
tively (Fig. 2C). Significantly, there was no detectable peak at
13 kDa (Fig. 2B), the expected size of a monomer. Increasing
the salt concentration to 500mM did not disrupt the amount of
the dimer complex that was present (69%, s  1.6) and did not
generate any detectable monomers (Fig. 2D), suggesting that
this complex is stable. These data indicate that the Dma1 RING
domain preferentially forms a stable dimer complex in vitro.
Residues in the C-terminal Tail Are Critical for Dma1
Dimerization—To identify specific residues that are required
for Dma1 dimerization, we generated a homology-basedmodel
of the Dma1 RING domain from the known structure of the
homodimeric RNF4 RING domain (8). From this model, sev-
eral residues were identified that appeared in the dimer inter-
face and that are also conserved in other Schizosaccharomyces
Dma1 proteins and in the Saccharomyces cerevisiae Dma1 and
Dma2 proteins (Fig. 3A). Selected residues were then mutated
in the Dma1(187–end) fragment and tested for interaction in a
yeast two-hybrid assay. Mutation of Phe-206 to alanine or Leu-
241 and Val-245 together to alanine disrupted self-interaction
(Fig. 3, B and C).
To validate that the Dma1(L241A,V245A) and Dma1-
(F206A) mutants were monomeric in vivo, we con-
FIGURE 3. Phe-206, Leu-241, and Val-245 are critical for Dma1 dimerization. A, ClustalW alignment of the RING domain and C-terminal flanking residues
from S. cerevisiae (Sc.c.) Dma1 (YNL116W) and Dma2 (YHR115C) and Schizosaccharomyces Dma1 homologs: S. pombe (Sz.p.; SPAC17G8.10c), Schizosaccharo-
myces japonicus (Sz.j.; SJAG02169.4), Schizosaccharomyces octosporus (Sz.o.; SOCG04269.5), and Schizosaccharomyces cryophilus (Sz.c.; SPOG00270.3). Amino
acid numbers correspond to S. pombe Dma1 amino acid positions. Conserved residues are highlighted, and asterisks indicate amino acids that were tested for
involvement in self-interaction. The dashed line indicates the region of Dma1 that was dispensable for self-interaction in yeast two-hybrid experiments. The
gray bar underlines the C-terminal flanking residues that were required for self-interaction in two-hybrid experiments. The black bar underlines the core RING
residues. B, yeast two-hybrid interactions. All point mutations were made in the Dma1(187– end) fragment and used as both bait and prey. C, summary of point
mutations that were tested for two-hybrid interaction. , interaction comparable with the wild type; , interaction weaker than the wild type; , no
interaction detected. RF, RING finger. D, co-immunoprecipitation experiments from dma1-3-V5/dma1-3-FLAG, dma1(L241A,V245A)-3-V5/dma1(L241A,V245A)-
3-FLAG, and dma1(F206A)-3-V5/dma1(F206A)-3-FLAG diploid cells. IP, immunoprecipitation; WB, Western blot.
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structed dma1(L241A,V245A)-3-V5/dma1(L241A,V245A)-3-
FLAG and dma1(F206A)-3-V5/dma1(F206A)-3-FLAG dip-
loids and performed a reciprocal co-immunoprecipitation
experiment. Although Dma1-3-FLAGwas able to interact with
Dma1-3-V5, Dma1(L241A,V245A)-3-FLAG did not pull down
a detectable amount of Dma1(L241A,V245A)-3-V5 or vice
versa (Fig. 3D), suggesting that Dma1(L241A,V245A) primarily
exists as a monomer in vivo. Similarly, Dma1(F206A)-3-V5 did
not coprecipitate with Dma1(F206A)-3-FLAG (Fig. 3D). Col-
lectively, these data confirm that residues in the core RING
domain, as well as residues in the C-terminal tail flanking the
RING domain, are important for Dma1 dimerization.
Dma1 Dimerization Is Required for Proper Localization—To
determine how dimerization affects Dma1 function in vivo, we
first wanted to examine if disruptingDma1 dimerization affects
its stability or localization. Dma1-GFP, Dma1(L241A,V245A)-
GFP, and Dma1(F206A)-GFP protein levels were compared,
and no changes in total protein levels were detected (Fig. 4A).
There were also no detectable differences in the amount of
protein that could be immunoprecipitated (Fig. 4A), indicating
that the amount of soluble protein is also not affected. Thus, it
is unlikely that disrupting the oligomerization state of Dma1
affects its protein stability.
We next examined where constitutively monomeric Dma1
localizes. Dma1 normally localizes to both SPBs during mitosis
and also to the cell division site, and localization to these sites is
dependent on its FHA domain (5). Surprisingly, we found
that both Dma1(L241A,V245A)-GFP and Dma1(F206A)-GFP
mutants localized strongly to just one of the two SPBs during
mitosis and had significantly reduced localization at the cell
division site (Fig. 4B). As expected, monomeric Dma1 still
required its FHA domain to localize to the one SPB because
inactivating the FHA domain (R64A) abolished Dma1-
(L241A,V245A)-GFP localization to all structures (Fig. 4C).
During early mitosis, the SIN is first activated on both SPBs,
and then during anaphase, it becomes inactivated on one SPB
FIGURE 4. Monomeric Dma1 exhibits defective intracellular localization. A, protein levels of Dma1-GFP, Dma1(L241A,V245A)-GFP, and Dma1(F206A)-GFP.
The Cdc2 blot is shown as a protein loading control. WB, Western blot; IP, immunoprecipitation. B, Dma1-GFP, Dma1(L241A,V245A)-GFP, or Dma1(F206A)-GFP
was imaged with Sid4-red fluorescent protein (RFP; magenta) in live cells. Scale bar  5 m. C, Dma1(R64A,L241A,V245A)-GFP localization. Scale bar  5 m.
D, representative live cell image of Dma1(L241A,V245A)-GFP with Cdc7-mCherry3 (n  five cells). Scale bar  5 m. E, pREP42-GFP-dma1(L241A,V245A) was
overproduced in dma1 cells, and the cells were imaged live. Scale bar  5 m. BF, bright field.
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and hyperactivated on the other SPB (21). Asymmetric activa-
tion of the SIN is governed by asymmetric distribution of spe-
cific SIN proteins and is important for precise timing of cytoki-
nesis (22). Because Dma1 is a SIN inhibitor, we wanted to
determine to which SPB monomeric Dma1 predominantly
localizes. Thus, we imagedDma1(L241A,V245A)-GFPwith the
SIN kinase Cdc7, which localizes only to the SPB with active
SIN signaling during anaphase (23). Co-imaging of Dma1-
(L241A,V245A)-GFP with Cdc7-3-mCherry showed that
Dma1(L241A,V245A)-GFP always localized to the opposite
SPB as Cdc7 (Fig. 4D), indicating that monomeric Dma1 local-
izes predominantly to the SPB in which the SIN is inactive.
Given that a small amount ofmonomericDma1was detected
at the cell division site, we reasoned that Dma1 might have
reduced localization everywhere and was strongly detectable
only at one SPB. Consistent with this idea, overexpression of
GFP-dma1(L241A,V245A) restored localization to both SPBs
and the cell division site (Fig. 4E). Collectively, these data indi-
cate that dimerization is required for proper Dma1 localization
at SPBs and the cell division site.
Dimerization of Dma1 Is Essential for Its E3 Ligase Activity
and Checkpoint Function—During a mitotic checkpoint,
Dma1 is required to inhibit cytokinesis to prevent chromosome
missegregation (5, 6). To test whether the oligomeric status of
Dma1 affects its function, we assessed whether dma1-
(L241A,V245A) or dma1(F206A) cells couldmaintain a mitotic
checkpoint arrest. Cells were synchronized in S-phase with
hydroxyurea and released to 18 °C to activate the spindle check-
point (using the cold-sensitive -tubulin mutant nda3-
KM311). Septation indices were measured at 0 and 7 h. At 7 h,
only 6.5% of nda3-KM311 dma1 cells had slipped from the
arrest, whereas 41.8% of nda3-KM311 dma1, 36.7% of nda3-
KM311 dma1(L241A,V245A), and 36% of nda3-KM311
dma1(F206A) cells had slipped from the arrest (Fig. 5,A and B).
These data indicate that dimerization is required for check-
point function.
Dma1 can autoubiquitinate in vitro (7), and we decided to
test whether the defect in checkpoint function observed in
the mutants was due to mislocalization alone or if it was
also due to compromised E3 ligase activity. Dma1-GFP,
Dma1(L241A,V245A)-GFP, and Dma1(F206A)-GFP were
immunoprecipitated and incubated with an E1 enzyme and the
E2 enzyme complex Ubc13-Uev1 for 90 min. Autoubiquiti-
nated proteins were detected by immunoblotting with anti-
GFP antibody. In contrast to Dma1-GFP, neither monomeric
mutant could form polyubiquitin chains in vitro (Fig. 5C), indi-
cating that they are not active E3 enzymes. We further tested
the activity of the monomeric mutants in vivo by examining
Sid4 ubiquitination, a known target of Dma1. Consistent with
the in vitro analysis, Sid4 ubiquitination was abolished in cells
expressing either dma1(L241A,V245A) or dma1(F206A) (Fig.
5D). Collectively, these data indicate that loss of checkpoint
function in dma1(L241A,V245A) and dma1(F206A) cells is due
to mislocalization and loss of E3 ligase activity.
DISCUSSION
Several RING E3 ligases form obligate homo- or het-
erodimers to efficiently transfer ubiquitin onto their substrates
(2). Here, we show that S. pombe Dma1 joins this subset of
dimeric E3 ligases by forming a homodimer via its RING
domain and that Dma1 dimerization is required for its E3 ligase
activity and checkpoint function in vivo. We also found that
similar to other C-terminal RING domain proteins, such as
RNF4 (8), Dma1 requires the C-terminal tail to dimerize. The
extra C-terminal extension likely provides stability to the dimer
or is required for proper folding of the RING domain.
Although we have shown that Dma1 self-associates in vivo
and preferentially forms a dimer when the RING domain is
expressed in vitro, we cannot exclude the possibility that Dma1
interacts with another RING E3 ligase to form a heteromulti-
mer complex. However, we have not identified another RING
E3 enzyme that co-purifies significantly with Dma1 in pro-
teomics screens (data not shown).WhetherDma1 ever exists as
a monomer in vivo also remains uncertain; however, the dimer
status of Dma1 is probably not a major point of regulation
because its self-association does not appear to increase signifi-
cantly during a mitotic checkpoint compared with asynchro-
FIGURE 5. Dimerization of Dma1 is essential for its checkpoint function
and E3 ubiquitin ligase activity. A, checkpoint assay with nda3-KM311
dma1, nda3-KM311 dma1, nda3-KM311 dma1(L241A,V245A), and nda3-
KM311 dma1(F206A) cells. Cells were synchronized in S-phase with
hydroxyurea and released at 18 °C to activate the spindle checkpoint. Septa-
tion indices were measured at 0 and 7 h (n  3). *, p  0.05 compared with
nda3-KM311 dma1. B, representative images of cells from the 7-h time point
for each strain indicated stained with DAPI and methyl blue. Scale bar  10
m. C, in vitro ubiquitination assay. Dma1-GFP, Dma1(L241A,V245A)-GFP,
and Dma1(F206A)-GFP were immunoprecipitated and incubated with an E1
activating enzyme, ATP, and ubiquitin with () or without () the E2 conju-
gating enzyme complex Ubc13-Uev1. Ubiquitinated proteins were detected
by immunoblotting with anti-GFP antibody. WB, Western blot. D, Sid4 ubiq-
uitination in vivo. Sid4 was immunoprecipitated with anti-Sid4 antibody,
treated with -protein phosphatase (-ppase) to visualize the ubiquitin lad-
der more clearly, and resolved by SDS-PAGE. Ubiquitinated proteins were
detected by immunoblotting with anti-Sid4 serum.
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nous cells (data not shown). It is more likely that Dma1 forms
an obligate and constitutive dimer that is regulated by other
mechanisms.
A surprising result was that a constitutivelymonomeric form
of Dma1 has significantly reduced localization at one SPB and
the cell division site. Importantly, Dma1 ubiquitination activity
is not required for proper localization (7), and thus, this pheno-
type is the direct result of the inability of Dma1 to dimerize. It is
not completely clear why the monomer localizes improperly,
but given thatDma1 requires its FHAdomain for localization, it
is possible that the presence of two FHA domains versus one
increases the affinity of Dma1 for its interaction partners.
Another possibility is that monomeric Dma1 lacks specific
binding surface(s) that are generated upon dimerization and
are required for proper Dma1 localization.
Many proteins localize asymmetrically to one SPB, including
several components of the SIN, and asymmetric SIN signaling is
critical for proper timing of cytokinesis (22). It is interesting
that constitutively monomeric Dma1 is observed only at the
SPB inwhich the SIN is inactive during anaphase. Ifmonomeric
Dma1 binds with less affinity to all Dma1 partners, thenmono-
meric Dma1might be detectable only at locations where Dma1
normally has the highest affinity. This is supported by our
observation that when the monomeric form is overexpressed,
Dma1 localization at both SPBs and the cell division site is
restored. Collectively, our data suggest that Dma1 has a stron-
ger affinity for the inactive SPB, where it can contribute more
robustly to SIN inactivation.
Although it was previously assumed that RING E3 ligases act
mainly as scaffolds to bring E2Ub and the substrate into prox-
imity, increasing evidence indicates that E3 ligases actively par-
ticipate in catalysis in several ways (2). It is also becoming evi-
dent that oligomerization of many RING E3 ligases enhances
their catalytic roles; however, it is not completely understood
why this is the case. Some studies suggest that oligomerized E3
ligases allosterically activate their cognate E2 enzymes more
efficiently to destabilize the E2Ub thioester bond and pro-
mote catalysis of ubiquitin onto the substrate (3, 8). Even more
recently, it was shown that the ubiquitin-loaded E2 enzyme
(E2Ub) binds across homodimeric RNF4 such that one RING
domain contacts the E2 enzyme, whereas the other RING
domain of theRNF4dimer contacts a hydrophobic patch on the
conjugated ubiquitin (15). Both interactions are necessary to
efficiently activate the thioester bond for catalysis, and spatial
constraints prevent a single RING domain from binding both
E2 and the conjugated ubiquitin.
Dma1 is a member of a small class of proteins that contain
both FHA and RING domains (16). Two homologs exist in
humans, CHFR (24) and RNF8 (25), and two redundant
homologs exist in S. cerevisiae, Dma1 and Dma2 (26), which,
similar toDma1, have roles in checkpoint signaling (16). To our
knowledge, S. pombe Dma1 is the first example from this class
of proteins that has been shown to form an obligate RING
domain dimer. Structure-function studies of the other RING
domains in the FHA-RING proteins will be required to deter-
mine whether RING dimerization is a conserved property of
this class or a unique property ofDma1.Given the propensity of
RING domain-containing proteins to dimerize, coupled with
the structural and functional similarities that exist between the
FHA-RING family members, it is plausible that they also func-
tion as homodimers, making this an interesting mechanistic
model for further investigation.
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